Treatment adherence and outcome in women with inflammatory breast cancer: Does race matter?

Cancer

Volumn 117, Issue 24, 2011, Pages 5485-5492

  Andic, Fundagul ^a,b   Godette, Karen ^a   O'Regan, Ruth ^c   Zelnak, Amelia ^c   Liu, Tian ^a   Rizzo, Monica ^a   Gabram, Sheryl ^a   Torres, Mylin ^a,c  

^a EMORY UNIVERSITY   (United States)

^b CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African American; combined therapy; inflammatory breast cancer; race; treatment adherence

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PACLITAXEL; PROGESTERONE RECEPTOR; TRASTUZUMAB;

ADJUVANT THERAPY; ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; AXILLARY LYMPH NODE; CANCER CONTROL; CANCER GRADING; CANCER RADIOTHERAPY; CAUCASIAN; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INFLAMMATORY BREAST CANCER; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; RACE DIFFERENCE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AFRICAN AMERICANS; AGED; COMBINED MODALITY THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INFLAMMATORY BREAST NEOPLASMS; MIDDLE AGED; NEOADJUVANT THERAPY; PATIENT COMPLIANCE; TREATMENT OUTCOME;

EID: 82955212950     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26187     Document Type: Article

References (20)

1. Haagensen Caucasian. Diseases of the Breast. 2nd ed. Philadelphia, PA: Saunders, 1971; 576-584.
2. Levine P, Steinhorn S, Ries L, et al. Inflammatory breast cancer. The experience of the Surveillance Epidemiology and End Results (SEER) program. J Natl Cancer Inst. 1985; 74: 291-297. (Pubitemid 15112115)
3. Chang S, Parker S, Pham T, et al. Inflammatory breast carcinoma incidence and survival. The Surveillance Epidemiology and End Results (SEER) Program of the National Cancer Institute, 1975-1992. Cancer. 1998; 82: 2366-2372. (Pubitemid 28283443)
4. Yang R, Cheung MC, Franceschi D, et al. African-American and low-socioeconomic status patients have a worse prognosis for invasive ductal and lobular breast carcinoma: do screening criteria need to change? J Am Coll Surg. 2009; 208: 853-868.
5. Fields JN, Perez CA, Kuske RR, et al. Inflammatory carcinoma of the breast: treatment results on 107 patients. Int J Radiat Oncol Biol Phys. 1989; 17: 249-255. (Pubitemid 19203069)
6. Krutchik AN, Buzdar AU, Blumenschein GR, et al. Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma. J Surg Oncol. 1979; 11: 325-332. (Pubitemid 9215215)
7. Hance KW, Anderson WF, Devesa SS, et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst. 2005; 97: 966-975. (Pubitemid 41430562)
8. Yang R, Cheung MC, Hurley J, et al. A comprehensive evaluation of outcomes for inflammatory breast cancer. Breast Cancer Res Treat. 2009; 117: 631-641.
9. Joslyn SA, West MM,. Racial differences in breast carcinoma survival. Cancer. 2000; 88: 114-123. (Pubitemid 30027686)
10. Wojcik BE, Spinks MK, Optenberg SA,. Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer. 1998; 82: 1310-1318. (Pubitemid 28155393)
11. Yood MU, Johnson CC, Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999; 91: 1487-1491. (Pubitemid 29424554)
12. Henson DE, Chu KC, Levine PH,. Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women. Cancer. 2003; 98: 908-917. (Pubitemid 37022089)
13. Elledge RM, Clark GM, Chamness GC, et al. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994; 86: 705-712. (Pubitemid 24138977)
14. Mohla S, Sampson CC, Khan T, et al. Estrogen and progesterone receptors in breast cancer in black Americans: correlation of receptor data with tumor differentiation. Cancer. 1982; 50: 552-559. (Pubitemid 12097427)
15. Rizzo M, Lund MJ, Mosunjac M, et al. Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer. Cancer. 2009; 115: 3009-3015.
16. Chen VW, Correa P, Kurman RJ, et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev. 1994; 3: 127-135. (Pubitemid 24170054)
17. Lund MJ, Trivers KF, Porter PL, et al. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat. 2009; 113: 357-370.
18. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006; 295: 2492-2502. (Pubitemid 43854964)
19. Aziz H, Hussain F, Sohn C, et al. Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol. 1999; 22: 436-440. (Pubitemid 30263286)
20. American Joint Committee on Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.